Preview Mode Links will not work in preview mode

GRACEcast


Aug 27, 2015

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).